Summary
Perfluorocarbons (PFCs), chemically inert fluorinated organic compounds with high binding capacity for O2, are under discussion as substitutes for erythrocytes. Given the paucity of E.M. observations after their use, the aim of this study was to provide more extensive ultrastructural data about PFC particle size in the emulsion and about the localization pattern in organs of rats after infusion of Fluosol 43. Attention has been focused on the particle relationships with subcellular structures and on the subsequent histopathological implications.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bucala R, Kawakami M, Cerami A (1983) Cytotoxicity of a perfluorocarbon blood substitute to macrophages in vitro. Science 220:965–967
Caiazza S, Fanizza C, Ferrari M (1983) Rapid dimensional characterization of perfluorocarbon (PFC) particles by means of EM and automatic image analysis methods. Micron Microsc Acta 14:357–360
Castro O, Reindorf CA, Socha WW, Rowe AW (1983) Perfluorocarbon enhancement of heterologous red cell survival: a reticuloendothelial block effect? Int Arch Allergy Appl Immunol 70:88–91
Clark LC, Gollan F (1966) Science 152:1755–1756
Dixon DD, Holland DG (1975) Fluorocarbons: properties and syntheses. Fed Proc 34:1444–1448
Fujta T, Suyama I, Yokoyama K (1973) Fluorocarbon emulsion as a candidate for artificial blood. Eur Surg Res 3:436–453
Geyer RP (1973) Fluorocarbon-polyol artificial blood substitutes. N Engl J Med 289:1077–1082
Hammarstrom M, Mullins R, Sgoutas D (1983) Effect of Fluosol-DA on radioimmunoassay results. Clin Chem 29:1418–1421
Kitazawa M, Ohnishi Y (1982) Long term experiment of perfluorochemicals using rabbits. Virchows Arch [Pathol Anat] 398:1–10
Le Blanc M, Riess JG (1982) Artificial blood substitutes based on perfluorochemicals. In: Banks RE (ed) Preparation, properties, and industrial applications of organofluorine compounds. Ellis Horwood limited, Chichester, pp 83–138
Lutz J, Metzenauer P (1980) Effects of potential blood substitutes (perfluorochemicals) on rat liver and spleen. Pflügers Arch 387:175–181
Lutz J (1983) Studies on RES function in rats and mice after different doses of Fluosol. Progr Clin Biol Res 122:197–208
Marwick C (1983) FDA committee questions Fluosol efficacy; US approval not imminent. JAMA 250:2585–2586
Miller ML, Moore RE, Clark LC Jr (1978) Morphology and morphometry of the liver after infusion of perfluorochemical emulsions: an assessment of 19 selected compounds. In: Proceedings of the IV International Symposium on Perfluorochemical Blood Substitutes. Excerpta Medica, Kyoto, pp 81–97
Mitsuno T, Ohyanagi H, Naito R (1982) Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA). Ann Surg 195:60–69
Mitsuno T, Tabuchi Y, Ohyanagi H, Sugiyama T (1983) Further studies on intake and retention of PFC substance of Fluosol-DA in RES in humans. Progr Clin Biol Res 122:257–263
Naito R, Yokoyama K (1978, 1981) Perfluorochemical blood substitutes “FC-43” “Fluosol-DA 20% and 35%”. The Green Cross Corporation, Osaka, Japan, Technical Information Ser No. 5, 7
Nanney L, Fink LM, Lynch JB, Virmani R (1983) Perfluorocarbon (oxypherol) treatment induces morphologic changes in rabbit lung. Fed Proc 42:1269
Oda Y, Handa H, Nagasawa S, Naruo Y, Asato R, Yonekawa Y (1982) Efficacy of a blood substitute (Fluosol-DA, 20%) on cerebral ischemia. Neurol Res 4:35–45
Ohnishi Y, Kitazawa M (1980) Application of perfluorochemicals in human beings. Acta Pathol Jpn 30:489–504
Pfannkuch F, Schnoy N (1983) Long-term observation of PFC storage in organs of rats after various dosages. Progr Clin Biol Res 122:209–219
Rosenblum WI, Hadfield MG, Martinez AJ, Sebatzki P (1976) Alterations of liver and spleen following intravenous infusion of fluorocarbon emulsions. Arch Pathol Lab Med 100:213–217
Schnoy N, Pfannkuch F (1980) Elektronenoptische Untersuchungen zur Fluorocarbon-Ausscheidung und Aufnahme in der Lunge. Virchows Arch [Cell Pathol] 34:269–276
Tremper KK, Friedman AE, Levine EM, Lapin R, Camarillo D (1982) The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med 307:277–283
Vercellotti GM, Hammerschmidt DE, Craddock PR, Jacob HS (1982) Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroid prophylaxis. Blood 59:1299–1304
Virmani R, Warren D, Rees R, Fink LM, English D (1983) Effects of perfluorochemical on phagocytic function of leukocytes. Transfusion 23:512–515
Yokoyama K, Yamanouchi K, Watanabe M, Matsumoto T, Murashima R, Daimoto T, Hamano T, Okamoto H, Suyama T, Watanabe R, Naito R (1975) Preparation of perfluorodecalin emulsion, an approach to the red cells substitute. Fed Proc 34:1478–1483
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caiazza, S., Fanizza, C. & Ferrari, M. Fluosol 43 particle localization pattern in target organs of rats. Vichows Archiv A Pathol Anat 404, 127–137 (1984). https://doi.org/10.1007/BF00704058
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00704058